液态氟碳超声造影剂在分子显影及治疗中的研究进展  

Progress in Molecular Development and Therapeutic Effect of Perfluorooctylbromide Ultrasound Contrast Agent

作　　者：尚艳文[1] 唐红[1] 

机构地区：[1]四川大学华西医院心内科,四川成都610041

出　　处：《心血管病学进展》2013年第4期537-540,共4页Advances in Cardiovascular Diseases

基　　金：国家自然科学基金面上项目(批准号30872535);四川省科技支撑项目(2008SZ0198)资助

摘　　要：液态氟碳纳米微球是一种新型的超声造影剂,它粒径小,稳定性好,显影方式为聚集显影。目前国外已有成功靶向血栓显影的报道,另外,液态氟碳超声造影剂被证实具有减轻炎症反应、保护心肌功能的作用。这篇综述将从其分子显影和治疗作用方面进行讨论。The perfluorooctylbromide particle is an ultrasound contrast agent.It is a small particle that has excellent stability and gathered development.The perfluorooctylbromide particle was also shown to alleviate the inflammation reaction and protect myocardium function.This review discusses the molecular development of perfluorooctylbromide and its therapeutic effect.

关 键 词：液态氟碳 超声造影剂 靶向 分子显影 治疗 

分 类 号：R445.1[医药卫生—影像医学与核医学]